Outcome of ProCol, a bovine mesenteric vein graft, in infrainguinal reconstruction - PubMed (original) (raw)
Outcome of ProCol, a bovine mesenteric vein graft, in infrainguinal reconstruction
A J Kovalic et al. Eur J Vasc Endovasc Surg. 2002 Dec.
Free article
Abstract
Objectives: historically infrainguinal reconstruction using heterogenous grafts has given poor results due to degradation and aneurysmal dilatation of the graft. A recently introduced heterogenous graft, the ProCol (bovine mesenteric vein) graft, may yield improved results. There are no published reports with respect to ProCol in infrainguinal reconstruction and hence we have reviewed our initial experience with this graft.
Methods: retrospective analysis of six patients in whom infrainguinal reconstruction with ProCol was undertaken between March and August 2001.
Results: the primary patency rate was 0% at 3 months, with grafts failing between 4 and 113 days. Two grafts underwent aneurysmal dilatation.
Conclusion: we are unable to recommend use of the ProCol graft in infrainguinal reconstruction.
Similar articles
- Early thrombosis in bovine mesenteric vein grafts after infrainguinal reconstruction.
Manduz S, Katrancioglu N, Ozker E, Dogan K. Manduz S, et al. Int J Angiol. 2008 Spring;17(1):37-9. doi: 10.1055/s-0031-1278278. Int J Angiol. 2008. PMID: 22477370 Free PMC article. - Bovine mesenteric vein graft (ProCol) in critical limb ischaemia with tissue loss and infection.
Schmidli J, Savolainen H, Heller G, Widmer MK, Then-Schlagau U, Baumgartner I, Carrel TP. Schmidli J, et al. Eur J Vasc Endovasc Surg. 2004 Mar;27(3):251-3. doi: 10.1016/j.ejvs.2003.12.001. Eur J Vasc Endovasc Surg. 2004. PMID: 14760592 - Superficial femoral eversion endarterectomy combined with a vein segment as a composite artery-vein bypass graft for infrainguinal arterial reconstruction.
Presti C, Puech-Leão P, Albers M. Presti C, et al. J Vasc Surg. 1999 Mar;29(3):413-21. doi: 10.1016/s0741-5214(99)70269-7. J Vasc Surg. 1999. PMID: 10069905 - Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
Dörffler-Melly J, Büller HR, Koopman MM, Prins MH. Dörffler-Melly J, et al. Cochrane Database Syst Rev. 2003;(4):CD000536. doi: 10.1002/14651858.CD000536. Cochrane Database Syst Rev. 2003. PMID: 14583924 Updated. Review. - Reinforced long saphenous vein bypass graft for infrainguinal reconstruction procedures: case series and literature review.
Hynes N, Mahendran B, Tawfik S, Sultan S. Hynes N, et al. Vascular. 2006 Mar-Apr;14(2):113-8. doi: 10.2310/6670.2006.00005. Vascular. 2006. PMID: 16956481 Review.
Cited by
- The Tissue-Engineered Vascular Graft-Past, Present, and Future.
Pashneh-Tala S, MacNeil S, Claeyssens F. Pashneh-Tala S, et al. Tissue Eng Part B Rev. 2016 Feb;22(1):68-100. doi: 10.1089/ten.teb.2015.0100. Epub 2015 Oct 8. Tissue Eng Part B Rev. 2016. PMID: 26447530 Free PMC article. - Preparation and characterization of small-diameter decellularized scaffolds for vascular tissue engineering in an animal model.
Xu S, Lu F, Cheng L, Li C, Zhou X, Wu Y, Chen H, Zhang K, Wang L, Xia J, Yan G, Qi Z. Xu S, et al. Biomed Eng Online. 2017 May 11;16(1):55. doi: 10.1186/s12938-017-0344-9. Biomed Eng Online. 2017. PMID: 28494781 Free PMC article. - Early thrombosis in bovine mesenteric vein grafts after infrainguinal reconstruction.
Manduz S, Katrancioglu N, Ozker E, Dogan K. Manduz S, et al. Int J Angiol. 2008 Spring;17(1):37-9. doi: 10.1055/s-0031-1278278. Int J Angiol. 2008. PMID: 22477370 Free PMC article. - Long-term outcomes of Omniflow II biosynthetic vascular graft in lower extremity arterial revascularization.
Toktaş F, Çayır MÇ, Özsin KK, Yavuz Ş, Göncü MT. Toktaş F, et al. Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Jul 3;26(3):407-413. doi: 10.5606/tgkdc.dergisi.2018.15689. eCollection 2018 Jul. Turk Gogus Kalp Damar Cerrahisi Derg. 2018. PMID: 32082771 Free PMC article. - Stem Cell Sources and Graft Material for Vascular Tissue Engineering.
Hielscher D, Kaebisch C, Braun BJV, Gray K, Tobiasch E. Hielscher D, et al. Stem Cell Rev Rep. 2018 Oct;14(5):642-667. doi: 10.1007/s12015-018-9825-x. Stem Cell Rev Rep. 2018. PMID: 29860617 Review. No abstract available.